We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCP Well Poised on Accretive Transactions: Time to Buy?
Read MoreHide Full Article
We updated our research report on HCP, Inc. (HCP - Free Report) on Aug 26, 2016. This Irvine, CA-based healthcare real estate investment trust (“REIT”) is engaged in acquiring, developing, managing, selling and leasing a diverse portfolio of healthcare real estate related properties.
HCP is banking on accretive acquisitions with solid, risk-adjusted returns to keep its growth momentum going. For the full year 2015, the company made total investments worth $2.1 billion with the trend continuing in 2016. In fact, during the second quarter and through Aug 8, the company declared investment transactions to the tune of $111 million, taking the year to date investments to $475 million. These investments offer a solid growth platform for HCP.
In addition, HCP has one of the most diversified, high-quality and well-balanced portfolios in the healthcare sector with exposure to all types of facilities. The diverse product mix of the company allows it to explore the opportunities available in various areas. Further, aging population, long-term leases, decent cash-flows and strong dividend payments augur well for the company.
On Aug 9, HCP reported second-quarter 2016 adjusted funds from operations (“FFO”) per share of 74 cents, beating the Zacks Consensus Estimate of 70 cents. Results were driven by better-than-expected growth in revenues.
The stock presently carries a Zacks Rank #2 (Buy).
Investors interested in the REIT sector can consider other favorably ranked stocks like Alexandria Real Estate Equities, Inc. (ARE - Free Report) , Arbor Realty Trust Inc. (ABR - Free Report) and CareTrust REIT, Inc. (CTRE - Free Report) . All these stocks hold the same Zacks Rank as HCP.
Note: All EPS numbers presented in this write-up represent funds from operations (“FFO”) per share. FFO, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
HCP Well Poised on Accretive Transactions: Time to Buy?
We updated our research report on HCP, Inc. (HCP - Free Report) on Aug 26, 2016. This Irvine, CA-based healthcare real estate investment trust (“REIT”) is engaged in acquiring, developing, managing, selling and leasing a diverse portfolio of healthcare real estate related properties.
HCP is banking on accretive acquisitions with solid, risk-adjusted returns to keep its growth momentum going. For the full year 2015, the company made total investments worth $2.1 billion with the trend continuing in 2016. In fact, during the second quarter and through Aug 8, the company declared investment transactions to the tune of $111 million, taking the year to date investments to $475 million. These investments offer a solid growth platform for HCP.
In addition, HCP has one of the most diversified, high-quality and well-balanced portfolios in the healthcare sector with exposure to all types of facilities. The diverse product mix of the company allows it to explore the opportunities available in various areas. Further, aging population, long-term leases, decent cash-flows and strong dividend payments augur well for the company.
On Aug 9, HCP reported second-quarter 2016 adjusted funds from operations (“FFO”) per share of 74 cents, beating the Zacks Consensus Estimate of 70 cents. Results were driven by better-than-expected growth in revenues.
HCP INC Price
HCP INC Price | HCP INC Quote
The stock presently carries a Zacks Rank #2 (Buy).
Investors interested in the REIT sector can consider other favorably ranked stocks like Alexandria Real Estate Equities, Inc. (ARE - Free Report) , Arbor Realty Trust Inc. (ABR - Free Report) and CareTrust REIT, Inc. (CTRE - Free Report) . All these stocks hold the same Zacks Rank as HCP.
Note: All EPS numbers presented in this write-up represent funds from operations (“FFO”) per share. FFO, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>